Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Cegedim

Market Cap 155M 178M 143M 134M 250M 17.06B 255M 1.7B 658M 8.22B 669M 654M 28.59B P/E Ratio 2026 *
7.67x
P/E Ratio 2027 * 5.1x
Enterprise Value 333M 383M 307M 287M 537M 36.72B 548M 3.66B 1.42B 17.7B 1.44B 1.41B 61.54B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.45x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 179M
-10.75%-24.33%+1.39%+53.60% 579B
-6.55%-14.95%-46.84%+13.11% 202B
-1.73%-12.42%-47.96%-4.33% 109B
-2.84%+5.97%-37.31%+11.61% 47.83B
+2.40%-8.26%-69.34%+327.40% 40.56B
-2.00%+2.92%-33.48%+50.06% 28.3B
+1.19%-2.52%-43.13%+6.06% 14.09B
-1.06%-9.82%-30.76%-1.53% 11.8B
+1.39%-21.21%-52.50%+63.32% 9.71B
Average -1.69%-6.52%-39.99%+57.70% 115.83B
Weighted average by Cap. -7.10%-8.99%-20.07%+47.13%

Financials

2026 *2027 *
Net sales 660M 761M 609M 570M 1.07B 72.87B 1.09B 7.26B 2.81B 35.13B 2.86B 2.8B 122B 681M 785M 628M 588M 1.1B 75.16B 1.12B 7.49B 2.9B 36.23B 2.95B 2.88B 126B
Net income 21.25M 24.49M 19.59M 18.35M 34.29M 2.34B 35.01M 234M 90.47M 1.13B 91.92M 89.94M 3.93B 30.58M 35.24M 28.19M 26.41M 49.35M 3.37B 50.38M 336M 130M 1.63B 132M 129M 5.66B
Net Debt 178M 205M 164M 154M 287M 19.66B 293M 1.96B 758M 9.48B 771M 754M 32.95B 150M 173M 138M 129M 242M 16.52B 247M 1.65B 638M 7.96B 648M 634M 27.69B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!